A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease

Valeria R. Villella, Andrea Venerando, Giorgio Cozza, Speranza Esposito, Eleonora Ferrari, Romina Monzani, Mara C. Spinella, Vasilis Oikonomou, Giorgia Renga, Antonella Tosco, Federica Rossin, Stefano Guido, Marco Silano, Enrico Garaci, Yu Kai Chao, Christian Grimm, Alessandro Luciani, Luigina Romani, Mauro Piacentini, Valeria RaiaGuido Kroemer, Luigi Maiuri

Research output: Contribution to journalArticle

Abstract

Intestinal handling of dietary proteins usually prevents local inflammatory and immune responses and promotes oral tolerance. However, in ~ 1% of the world population, gluten proteins from wheat and related cereals trigger an HLA DQ2/8-restricted TH1 immune and antibody response leading to celiac disease. Prior epithelial stress and innate immune activation are essential for breaking oral tolerance to the gluten component gliadin. How gliadin subverts host intestinal mucosal defenses remains elusive. Here, we show that the α-gliadin-derived LGQQQPFPPQQPY peptide (P31–43) inhibits the function of cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel pivotal for epithelial adaptation to cell-autonomous or environmental stress. P31–43 binds to, and reduces ATPase activity of, the nucleotide-binding domain-1 (NBD1) of CFTR, thus impairing CFTR function. This generates epithelial stress, tissue transglutaminase and inflammasome activation, NF-κB nuclear translocation and IL-15 production, that all can be prevented by potentiators of CFTR channel gating. The CFTR potentiator VX-770 attenuates gliadin-induced inflammation and promotes a tolerogenic response in gluten-sensitive mice and cells from celiac patients. Our results unveil a primordial role for CFTR as a central hub orchestrating gliadin activities and identify a novel therapeutic option for celiac disease.

Original languageEnglish
Article numbere100101
JournalEMBO Journal
Volume38
Issue number2
DOIs
Publication statusPublished - 2018

Fingerprint

Gliadin
Cystic Fibrosis Transmembrane Conductance Regulator
Celiac Disease
Glutens
Chemical activation
Inflammasomes
Interleukin-15
Dietary Proteins
Abdomen
Triticum
Antibody Formation
Anions
Adenosine Triphosphatases
Epithelium
Nucleotides
Inflammation
Peptides
Antibodies
Population

Keywords

  • celiac disease
  • CFTR
  • gliadin
  • mucosal immunology
  • P31–43 peptide

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Villella, V. R., Venerando, A., Cozza, G., Esposito, S., Ferrari, E., Monzani, R., ... Maiuri, L. (2018). A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. EMBO Journal, 38(2), [e100101]. https://doi.org/10.15252/embj.2018100101

A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. / Villella, Valeria R.; Venerando, Andrea; Cozza, Giorgio; Esposito, Speranza; Ferrari, Eleonora; Monzani, Romina; Spinella, Mara C.; Oikonomou, Vasilis; Renga, Giorgia; Tosco, Antonella; Rossin, Federica; Guido, Stefano; Silano, Marco; Garaci, Enrico; Chao, Yu Kai; Grimm, Christian; Luciani, Alessandro; Romani, Luigina; Piacentini, Mauro; Raia, Valeria; Kroemer, Guido; Maiuri, Luigi.

In: EMBO Journal, Vol. 38, No. 2, e100101, 2018.

Research output: Contribution to journalArticle

Villella, VR, Venerando, A, Cozza, G, Esposito, S, Ferrari, E, Monzani, R, Spinella, MC, Oikonomou, V, Renga, G, Tosco, A, Rossin, F, Guido, S, Silano, M, Garaci, E, Chao, YK, Grimm, C, Luciani, A, Romani, L, Piacentini, M, Raia, V, Kroemer, G & Maiuri, L 2018, 'A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease', EMBO Journal, vol. 38, no. 2, e100101. https://doi.org/10.15252/embj.2018100101
Villella VR, Venerando A, Cozza G, Esposito S, Ferrari E, Monzani R et al. A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. EMBO Journal. 2018;38(2). e100101. https://doi.org/10.15252/embj.2018100101
Villella, Valeria R. ; Venerando, Andrea ; Cozza, Giorgio ; Esposito, Speranza ; Ferrari, Eleonora ; Monzani, Romina ; Spinella, Mara C. ; Oikonomou, Vasilis ; Renga, Giorgia ; Tosco, Antonella ; Rossin, Federica ; Guido, Stefano ; Silano, Marco ; Garaci, Enrico ; Chao, Yu Kai ; Grimm, Christian ; Luciani, Alessandro ; Romani, Luigina ; Piacentini, Mauro ; Raia, Valeria ; Kroemer, Guido ; Maiuri, Luigi. / A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. In: EMBO Journal. 2018 ; Vol. 38, No. 2.
@article{2faed478d3fc45e4a22efaa83845dc17,
title = "A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease",
abstract = "Intestinal handling of dietary proteins usually prevents local inflammatory and immune responses and promotes oral tolerance. However, in ~ 1{\%} of the world population, gluten proteins from wheat and related cereals trigger an HLA DQ2/8-restricted TH1 immune and antibody response leading to celiac disease. Prior epithelial stress and innate immune activation are essential for breaking oral tolerance to the gluten component gliadin. How gliadin subverts host intestinal mucosal defenses remains elusive. Here, we show that the α-gliadin-derived LGQQQPFPPQQPY peptide (P31–43) inhibits the function of cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel pivotal for epithelial adaptation to cell-autonomous or environmental stress. P31–43 binds to, and reduces ATPase activity of, the nucleotide-binding domain-1 (NBD1) of CFTR, thus impairing CFTR function. This generates epithelial stress, tissue transglutaminase and inflammasome activation, NF-κB nuclear translocation and IL-15 production, that all can be prevented by potentiators of CFTR channel gating. The CFTR potentiator VX-770 attenuates gliadin-induced inflammation and promotes a tolerogenic response in gluten-sensitive mice and cells from celiac patients. Our results unveil a primordial role for CFTR as a central hub orchestrating gliadin activities and identify a novel therapeutic option for celiac disease.",
keywords = "celiac disease, CFTR, gliadin, mucosal immunology, P31–43 peptide",
author = "Villella, {Valeria R.} and Andrea Venerando and Giorgio Cozza and Speranza Esposito and Eleonora Ferrari and Romina Monzani and Spinella, {Mara C.} and Vasilis Oikonomou and Giorgia Renga and Antonella Tosco and Federica Rossin and Stefano Guido and Marco Silano and Enrico Garaci and Chao, {Yu Kai} and Christian Grimm and Alessandro Luciani and Luigina Romani and Mauro Piacentini and Valeria Raia and Guido Kroemer and Luigi Maiuri",
year = "2018",
doi = "10.15252/embj.2018100101",
language = "English",
volume = "38",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease

AU - Villella, Valeria R.

AU - Venerando, Andrea

AU - Cozza, Giorgio

AU - Esposito, Speranza

AU - Ferrari, Eleonora

AU - Monzani, Romina

AU - Spinella, Mara C.

AU - Oikonomou, Vasilis

AU - Renga, Giorgia

AU - Tosco, Antonella

AU - Rossin, Federica

AU - Guido, Stefano

AU - Silano, Marco

AU - Garaci, Enrico

AU - Chao, Yu Kai

AU - Grimm, Christian

AU - Luciani, Alessandro

AU - Romani, Luigina

AU - Piacentini, Mauro

AU - Raia, Valeria

AU - Kroemer, Guido

AU - Maiuri, Luigi

PY - 2018

Y1 - 2018

N2 - Intestinal handling of dietary proteins usually prevents local inflammatory and immune responses and promotes oral tolerance. However, in ~ 1% of the world population, gluten proteins from wheat and related cereals trigger an HLA DQ2/8-restricted TH1 immune and antibody response leading to celiac disease. Prior epithelial stress and innate immune activation are essential for breaking oral tolerance to the gluten component gliadin. How gliadin subverts host intestinal mucosal defenses remains elusive. Here, we show that the α-gliadin-derived LGQQQPFPPQQPY peptide (P31–43) inhibits the function of cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel pivotal for epithelial adaptation to cell-autonomous or environmental stress. P31–43 binds to, and reduces ATPase activity of, the nucleotide-binding domain-1 (NBD1) of CFTR, thus impairing CFTR function. This generates epithelial stress, tissue transglutaminase and inflammasome activation, NF-κB nuclear translocation and IL-15 production, that all can be prevented by potentiators of CFTR channel gating. The CFTR potentiator VX-770 attenuates gliadin-induced inflammation and promotes a tolerogenic response in gluten-sensitive mice and cells from celiac patients. Our results unveil a primordial role for CFTR as a central hub orchestrating gliadin activities and identify a novel therapeutic option for celiac disease.

AB - Intestinal handling of dietary proteins usually prevents local inflammatory and immune responses and promotes oral tolerance. However, in ~ 1% of the world population, gluten proteins from wheat and related cereals trigger an HLA DQ2/8-restricted TH1 immune and antibody response leading to celiac disease. Prior epithelial stress and innate immune activation are essential for breaking oral tolerance to the gluten component gliadin. How gliadin subverts host intestinal mucosal defenses remains elusive. Here, we show that the α-gliadin-derived LGQQQPFPPQQPY peptide (P31–43) inhibits the function of cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel pivotal for epithelial adaptation to cell-autonomous or environmental stress. P31–43 binds to, and reduces ATPase activity of, the nucleotide-binding domain-1 (NBD1) of CFTR, thus impairing CFTR function. This generates epithelial stress, tissue transglutaminase and inflammasome activation, NF-κB nuclear translocation and IL-15 production, that all can be prevented by potentiators of CFTR channel gating. The CFTR potentiator VX-770 attenuates gliadin-induced inflammation and promotes a tolerogenic response in gluten-sensitive mice and cells from celiac patients. Our results unveil a primordial role for CFTR as a central hub orchestrating gliadin activities and identify a novel therapeutic option for celiac disease.

KW - celiac disease

KW - CFTR

KW - gliadin

KW - mucosal immunology

KW - P31–43 peptide

UR - http://www.scopus.com/inward/record.url?scp=85057485501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057485501&partnerID=8YFLogxK

U2 - 10.15252/embj.2018100101

DO - 10.15252/embj.2018100101

M3 - Article

C2 - 30498130

AN - SCOPUS:85057485501

VL - 38

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 2

M1 - e100101

ER -